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Background:  The fragile histidine triad (FHIT) protein is a member of the large
and ubiquitous histidine triad (HIT) family of proteins. It is expressed from a
gene located at a fragile site on human chromosome 3, which is commonly
disrupted in association with certain cancers. On the basis of the genetic
evidence, it has been postulated that the FHIT protein may function as a tumor
suppressor, implying a role for the FHIT protein in carcinogenesis. The FHIT
protein has dinucleoside polyphosphate hydrolase activity in vitro, thus
suggesting that its role in vivo may involve the hydrolysis of a
phosphoanhydride bond. The structural analysis of FHIT will identify critical
residues involved in substrate binding and catalysis, and will provide insights
into the in vivo function of HIT proteins.
Results:  The three-dimensional crystal structures of free and nucleoside
complexed FHIT have been determined from multiwavelength anomalous
diffraction (MAD) data, and they represent some of the first successful
structures to be measured with undulator radiation at the Advanced Photon
Source. The structures of FHIT reveal that this protein exists as an intimate
homodimer, which is based on a core structure observed previously in another
human HIT homolog, protein kinase C interacting protein (PKCI), but has
distinctive elaborations at both the N and C termini. Conserved residues within
the HIT family, which are involved in the interactions of the proteins with
nucleoside and phosphate groups, appear to be relevant for the catalytic
activity of this protein.
Conclusions:  The structure of FHIT, a divergent HIT protein family member, in
complex with a nucleotide analog suggests a metal-independent catalytic
mechanism for the HIT family of proteins. A structural comparison of FHIT with
PKCI and galactose-1-phosphate uridylyltransferase (GalT) reveals additional
implications for the structural and functional evolution of the ubiquitous HIT
family of proteins.
Introduction
The FHIT (fragile histidine triad) protein is a member of
a large and ubiquitous family of proteins termed the HIT
family due to a conserved histidine triad (His-X-His-X-
His) amino acid sequence motif found at the C-terminal
end of their polypeptide sequences [1,2]. Sequences cor-
responding to HIT proteins have been found in diverse
organisms, including Haemophilus influenzae, Methanococcus
jannaschii, Zea maize and Homo sapiens. Although amino
acid sequences from putative HIT genes can be aligned to
reveal at least two subfamilies within the superfamily, a
more correct functional classification of this family is not
complete. One subfamily, characterized by a highly con-
served C-terminal sequence, has greater than 94%
sequence identity over the entire protein length between
all known mammalian homologs. In addition, over 66%
amino acid sequence identity is observed in this subfamily
between organisms as diverse as humans and Caenorhabdi-
tis elegans, and over 58% identity is observed between
humans and the cyanobacterium Synechococcus sp. We have
previously described the identification, cloning and struc-
ture determination of human protein kinase C interacting
protein (PKCI), a member of the highly conserved HIT
subfamily, in its free form [3]. Recently, the structure of
the rabbit HIT protein homolog, renamed as HINT, has
been reported [4]. The rabbit HIT protein is 96% identi-
cal to human PKCI with five amino acid substitutions.
Although the rabbit HIT protein and human PKCI struc-
tures were not compared in detail, the sequence conserva-
tion suggests that they are virtually identical.
Members of a more divergent HIT subfamily, to which
FHIT belongs, share approximately 50% sequence iden-
tity between one another, but diverge significantly from
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the more conserved subfamily, of which PKCI is a
member, by the addition of a C-terminal amino acid
sequence extension. A core domain of approximately 100
amino acids has amino acid sequence similarity among all
HIT family members. PKCI and FHIT share only 20.7%
amino acid sequence identity over an 110 amino acid
overlap. We are now able to report the three-dimensional
MAD structures and subsequent analysis of a very diver-
gent HIT family member, FHIT, in both apo (free) and
partial ligand bound forms.
The FHIT gene was recently identified by an exon-trap-
ping strategy from cosmids covering a region of human
chromosome 3p14.2 involved in homozygous deletions in
epithelial cancer cell lines [5]. Subsequent genetic studies
of the FHIT locus show abnormalities and homozygous
deletions in several cell lines and primary tumors. From
these studies, it has been postulated that the FHIT
protein may function as a tumor suppressor when
expressed from this gene locus, thus implying a possible
role for FHIT in carcinogenesis [6–15]. A subsequent
genetic study focusing on FHIT in colorectal cancers sug-
gests that FHIT does not play a primary role in this type
of cancer [16]. It was recently reported that reciprocal
hybrid transcripts of HMGIC and FHIT are expressed in a
pleomorphic adenoma of the parotid gland, suggesting
that two tumor-associated genes are disrupted in a benign
tumor, again demonstrating the high level of recombina-
tion activity at this locus [17]. Definitive evidence sup-
porting the putative role for FHIT as a tumor suppressor
has yet to be elucidated.
FHIT has been shown to have sequence similarity (52%
identity over 110 amino acids) to a Schizosaccharomyces
pombe HIT family member, which has been previously
shown to have diadenosine 5′,5′′′-P1,P4-tetraphosphate
(Ap4A) asymmetrical hydrolase activity [18]. Dinucleoside
polyphosphates, which are primarily the by-products of
some tRNA synthetases, have been postulated to function
in vivo as messengers in cellular responses to growth con-
ditions and stress response [19]. It has recently been
demonstrated that the FHIT protein is capable of asym-
metrical cleavage of a broad range of dinucleoside
polyphosphates, which always yields a nucleotide
monophosphate [20]. FHIT shows a preference for
diadenosine 5′,5′′′-P1,P3-triphosphate (Ap3A) as a sub-
strate, in contrast to the S. pombe enzyme which prefers
Ap4A. In this reaction, FHIT reacts with Ap3A to yield
ADP and AMP products. It should be noted that both
enzymes cleave a broad range of substrates, but with
varying efficiencies depending on the substrate. These
previous studies report that catalysis is metal-dependent,
as the reactions between FHIT and its substrates can be
halted by the addition of EDTA. The present structural
study demonstrates that FHIT interacts with a nucleotide
analog in the absence of a divalent metal cation, thus,
enabling a detailed analysis of the critical residues
involved in binding and catalysis of nucleotide polyphos-
phates which are conserved among divergent HIT family
members. The structural analysis of FHIT, a diverse
human HIT family member, and PKCI will provide
insights into the in vivo function of HIT proteins.
Results and discussion 
Undulator MAD experiment and structure determination
The Structural Biology Center (SBC) beamline 19-ID at
the Advanced Photon Source (APS) utilizes an undulator
insertion device to generate very bright X-rays in narrow
tunable harmonic peaks. The APS operates at suitably
high particle energy to provide the first undulator har-
monic in the X-ray range for multiwavelength anomalous
diffraction (MAD) experiments at the K edge of selenium.
The structure of FHIT has been determined by MAD
phasing [21] using the selenomethionyl protein [22], in
both its free and adenosine/sulfate-bound forms. The data
for free and ligand-bound forms of FHIT were measured
with the SBC APS1 3×3 CCD array detector (CCD) [23]
and a FUJI image plate (IP) system, respectively. Both
four-wavelength experiments took advantage of the ability
to tune the peak of the harmonic by altering the gap width
of the undulator during data collection, as has been done
previously [24]. Three gap widths were chosen to center
the peak of the first harmonic at the wavelength of choice.
A single setting sufficed for peak and inflection points of
the selenium K edge, which are very close together. Both
experiments utilized crystals of the selenomethionyl-
FHIT protein, although one of the crystals was also
soaked in an adenosine/vanadate mixture in order to
obtain a complex between protein and nucleoside. The
nucleoside soak severely limited the diffraction quality of
this sample in comparison with the free form of the
protein. Although this enabled two independent structure
determinations, it hampered the ability to compare results
from the IP system and the CCD detector directly.
An almost complete set of phases was obtained by
MADSYS [21] analysis to 2.8Å spacings for the
FHIT–adenosine/sulfate complex IP data set. This gave a
fully interpretable Fourier map, whereupon the chain was
traced and all ordered amino acid residues were posi-
tioned. A partially complete phase set was calculated to
2.0Å spacings for the free FHIT CCD-data set, which
resulted in an incomplete and disconnected electron
density map. The limited extent of this data set was due
to a time constraint, which prevented the completion of
the experiment, and to an abundance of saturated low-
angle reflections (d>5.0Å). The addition of phased reflec-
tions out to 5.0Å spacings from the IP data set and density
modification [25] at 2.0 Å yielded readily interpretable
maps at 2.0Å resolution, which allowed the peptide chain
to be retraced and sidechains to be positioned [26].
Although these differences make it difficult to compare
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the strategies and detectors used in the two experiments,
the merging and phasing statistics from both experiments
demonstrate that undulator beamline 19-ID and the CCD
detector are capable of producing data of sufficient quality
for accurate MAD phasing (Tables 1–3; Fig. 1). Ultimately,
the native structure was refined against a more complete
and higher resolution data set that was measured at beam-
line X4A at the National Synchrotron Light Source.
FHIT structure description
The electron density for native FHIT was well-enough
defined to complete the model for residues 2–106 and
127–147, but not for the intervening segment or the first
residue. The Ca backbone from this model is shown in
Figure 2a for the FHIT dimer. Elution of FHIT upon size
exclusion chromatography suggests that it is a dimer in
solution (data not shown) and, although there is only one
chain per asymmetric unit in the crystal, a dimer inter-
action similar to that previously reported for the PKCI
dimer [3] is observed across a crystallographic twofold axis.
The overall structure of the FHIT protomer can be
described as a general a+b type and further subclassed as
an a+b meander fold [27]. The FHIT protomer contains
two helices, A and B, and seven b strands. These elements
are shown in the ribbon diagram of Figures 2b and c.
Strands three to seven form a five-stranded antiparallel
sheet and antiparallel strands one and two form a b hairpin
across from and at an angle to the other sheet. In the pro-
tomer, helix A packs on one side of the five-stranded
antiparallel sheet. Helix B packs on the same side of the
molecule as helix A and primarily interacts with strands
three and four and the loop connecting strands two and
three. Two protomers are brought together in the dimer by
interactions between helices A and A′ and by the formation
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Table 1
MAD diffraction data.
Data set Wavelength (Å) Reflections (unique/total)* Completeness (%) (I/s) Rsym (%)†
IP data set 0.9951 19709/81943 97.3 8.0 9.7
(10–2.2 Å) 0.9795 19775/83506 97.6 8.0 7.2
0.9793 19649/81873 96.9 8.0 7.2
0.9639 19907/84307 98.2 8.0 9.2
CCD data set 0.9951 21007/39596 55.5 44.4 2.5
(10–1.67 Å) 0.9795 41754/82995 65.2 51.3 3.5
0.9793 41857/84710 66.3 62.3 3.6
0.9639 43275/87495 67.1 48.6 3.9
*Unique reflections distinguish Bijvoet mates. †Rsym = S| I — < I> | /SI, where I = observed intensity and < I> = average intensity. 
Table 2
MAD phasing analysis.
Anomalous diffraction ratios*
pre-edge edge peak above edge f′ † f′′ †
IP data set (10–2.8 Å) pre-edge 0.042 0.077 0.078 0.037 –3.65 1.14
(0.039)
edge 0.057 0.046 0.077 –10.73 3.98
(0.034)
peak 0.073 0.077 –9.64 5.78
(0.039)
above edge 0.054 –3.62 3.83
(0.035)
CCD data set (8–2.0 Å) pre-edge 0.039 0.066 0.090 0.038 –3.60 1.10
(0.032)
edge 0.058 0.065 0.057 –10.06 4.26
(0.025)
peak 0.079 0.077 –10.21 6.10
(0.038)
above edge 0.051 –4.30 3.59
(0.029)
*Anomalous diffraction ratios = < D | F | 2>1/2/ < |F | 2>1/2, where D | F | is the absolute value of the Bijvoet (diagonal elements) or dispersive
difference (off diagonal elements), respectively. †f′ and f′′ are the refined values obtained from MADSYS [21].
of a ten-stranded antiparallel sheet comprising the respec-
tive five-stranded antiparallel sheet of each protomer. A
common hydrophobic core is formed from the protomer
interactions within the context of the dimer. The exten-
sive dimer interface occupies 2374Å2 per dimer compared
to the total dimer surface area of 11239Å2 as computed
with a probe radius of 1.4Å [28].
With the structure of FHIT at hand, the deletion of spe-
cific exons from the FHIT locus, which in turn codes for
the aberrant FHIT transcripts observed in many cancer
cell lines and primary tumors can be analyzed in terms of
protein structure [5–9]. Several of these aberrant tran-
scripts have been sequenced and details of the specific
deleterious effects on FHIT transcripts have been
described. Most of the observed deletions in the FHIT
gene either truncate or eliminate the coding regions. Spe-
cific exons are deleted in some cases leading to the possi-
bility of a fused protein. Several possible and observed
exonic deletions have been mapped onto the FHIT
protein structure, including a deletion of exons 8, 8 to 9, 5
to part of 6, 5 to 6, part of 6 to 9, 5 to 9 and 4 to 7. Analysis
of any of these deletions mapped onto the three-dimen-
sional structure lead us to believe that none of these
mutant proteins would fold and dimerize with the full
length FHIT protein; thus, it is unlikely if not impossible
to have a dominant negative phenotype when one copy of
the gene is found to be aberrant in length or sequence.
This does not exclude the possibility of dose-dependent
effects of FHIT expression when one copy of the gene has
been disrupted.
Comparison with PKCI, another human HIT family member
We recently reported the structure of free human PKCI .
Human PKCI was identified in a yeast two-hybrid screen
using protein kinase C b (PKC-b) as a probe and subse-
quently cloned from a HL60 cDNA library [3]. Although
the role for PKCI in cells is not clear at present, evidence
for the physiological role of the protein has been sug-
gested by interactions obtained in the yeast two-hybrid
assay between PKCI and PKC-b or ataxia-telangiectasia
group D complementing (ATDC) protein, a gene product
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Table 3
Anomalous phasing statistics.
R(° | FT | )* R(° | FA | )† <D(Df)>‡§ <s(Df)>
IP data set 0.082 0.464 46.26° 19.31°
CCD data set 0.049 0.308 30.93° 18.93°
*°FT is the structure factor due to normal scattering from all the atoms; †°FA is the structure factor due to normal scattering from the anomalous
scatterers only. ‡Df is the phase difference between °FT and °FA. §D(Df) is the difference between two independent determinations of Df.
Figure 1
Electron density for the active site histidine
region of FHIT. (a) Experimental electron
density generated with MAD phases from the
IP data set. The map is at 2.8 Å resolution and
is contoured at 1.0σ. (b) Experimental
electron density generated with MAD phases
from the CCD data set. The map is at 2.0 Å
resolution and is contoured at 1.0σ. (c)
Experimental electron density generated with
MAD phases from the CCD data set to 2.0 Å
spacing augmented with MAD phases and
reflections from the IP data set to 5.0 Å
spacing after density modification. The map is
contoured at 2.0σ. (Figure generated with O
[26].)
isolated for its ability to complement the ionizing radiation
sensitivity of AT group D fibroblasts [29]. PKCI has
recently been mapped to human chromosome 5q31.2 by
fluorescence in situ hybridization [30]. In our PKC-b
screen, PKCI was shown to interact specifically with the
regulatory domain of this PKC isoform. In the ATDC
screen, ATDC interacted with both vimentin and PKCI.
The first PKCI HIT homolog to be characterized bio-
chemically was bovine PKCI (94.4% identity over 126
amino acids with human PKCI) (Fig. 3). Bovine PKCI was
purified directly from brain, reported to be a potent
inhibitor of protein kinase C and was subsequently shown
to interact with zinc [31–36]. A HIT homolog from maize
(53% identity over 115 amino acids with human PKCI)
was identified, cloned and the protein biochemically char-
acterized. The maize HIT protein was shown to interact
with zinc and, albeit weakly, synergistically inhibit PKC in
the presence of 14-3-3 protein [31]. Since these experi-
ments were carried out, doubt has been cast on the ability
of these proteins to inhibit protein kinase C in vitro
[3,31,35]. Although previous studies demonstrate zinc
binding by some HIT proteins, we have shown by the
crystallographic analysis of PKCI at high resolution in the
presence and absence of zinc that zinc does not bind
specifically to this protein in the crystal lattice [3].
The amino acid sequences of PKCI and FHIT overlap
with a single gap and 20.7% identity spanning residues
1–110 of FHIT (Fig. 3); this value of sequence identity is
close to random. Nevertheless, the PKCI and FHIT three-
dimensional structures are quite similar for a core corre-
sponding to the five-stranded b sheet and helix A (FHIT),
but they diverge markedly at both ends. A least-squares
superposition of the 88-residue core (FHIT residues
14–101 and PKCI residues 30–117) gives a root mean
square deviation (rmsd) of 2.15Å between FHIT and
PKCI Ca atoms. The related helices (A in FHIT and B in
PKCI) have coincident axes, but they superimpose poorly
because of a divergence where PKCI is distorted at Gly75,
at a protomer–protomer contact (Fig. 4). Consequently, if
the helices are excluded from the least-squares calcula-
tions (FHIT residues 14–46 and 72–101 against PKCI
residues 30–62 and 92–117), the rmsd drops to 1.1Å. The
core structural similarity between FHIT and PKCI
extends to the entire dimer. The rmsd values for the
dimer superpositions of the entire core and for the b-sheet
substructure are 2.2 Å and 1.7Å, respectively. It is interest-
ing to note that the sequence similarity observed in the
N-terminal residues of PKCI and FHIT does not corre-
spond to a similar secondary structure in the two proteins
(Figs 3,4). The corresponding residues in FHIT that
make up strands one and two are helical in PKCI.
A major structural difference between FHIT and PKCI is
that the PKCI HIT subfamily has a highly conserved C-
terminal sequence involved in extensive protomer–pro-
tomer and PKCI–ligand interactions (Figs 3,4), which
apparently serves to segregate two large clefts, one in each
protomer, by interactions between the C-terminal amino
acids of each protomer. This segment in human PKCI has
the sequence Gly117-Gly-Arg-Gln-Met-His-Trp-Pro-Pro-
Gly126. These residues wrap around and interact with the
respective residues from the other protomer, ending in a
salt bridge between the C-terminal Gly126 of one PKCI
protomer and Arg119 of the other. FHIT lacks the con-
served sequence and subsequent interactions between
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Figure 2
The FHIT dimer. (a) Stereo Ca backbone
trace of FHIT with Ca atoms numbered every
ten amino acids. Numbering is differentiated
between protomers by use of a prime symbol.
(b,c) Orthogonal views of a Ca spline
Richardson style ribbon diagram of the FHIT
dimer with helical elements lettered A
(residues 52–72) and B (residues 132–141)
and beta elements numbered 1 (residues
2–4), 2 (residues 7–9), 3 (residues 15–19), 4
(residues 22–26), 5 (residues 34–40), 6
(residues 77–85), and 7 (residues 95–102).
Protomers are distinguished by use of a prime
symbol in the numbering scheme. The
disordered residues between amino acids
108 and 125 are indicated by a dashed line.
(These figures were generated using SETOR
[53].)
C-terminal amino acids, thus, creating a single large cleft
running from one ligand-binding site to the other. It
should be noted that FHIT residues 107–126 were not
sufficiently ordered for placement into electron density,
but the direction of the polypeptide chains preceding
these disordered residues and some observable electron
density within this region of disorder indicates that at least
some of these residues are located above the cleft where
the partial substrate is bound (see later discussions).
Ligand binding by HIT family members
General aspects of ligand binding for the HIT family can
be described based on the nucleotide-analog–FHIT
complex. Due to the very high concentrations of ammo-
nium sulfate in the crystallization and stabilization solu-
tions, it appears vanadate was unable to replace the bound
sulfate in the FHIT active site. The adenosine and sulfate
groups bound in the FHIT active site do, however, eluci-
date important interactions between the ligand and
protein. The ligand-binding site is located in a deep cleft
within each FHIT protomer, the floor of which is formed
from the five-stranded b sheet. The sides of the cleft are
formed from strands one and two, together with the loop
connecting strands six and seven on one side and helix B
and the loop between strands four and five on the other
side (Figs 2,5). Interactions between ligand and protein
include hydrophobic interactions, direct and water-medi-
ated hydrogen-bonding interactions, and the interactions
between active-site histidines 96 and 98 and the a phos-
phate group of the nucleotide analog. The nucleotide
analog–FHIT complex represents the FHIT product
complex in the asymmetric hydrolysis of Ap3A to ADP and
AMP. Although this study clearly shows how FHIT binds
the AMP product of its respective substrates, the compo-
nents of FHIT responsible for binding the remaining
portion of the substrate during catalysis remain elusive. As
stated previously in the text, the disordered loop in FHIT,
located above the active-site region, could close down on
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Figure 3
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Alignment of several HIT family members (only a subset of HIT family
members are depicted in the figure for clarity). Those sequences
included are Homo sapiens FHIT [6] (GenBank accession  (GB)
U46922), Schizosaccharomyces pombe HIT [54] (GB U32615),
Haemophilus influenzae HIT [55] (GB U32777), Methanococcus
junnaschii HIT [56] (GB U67530), Synechococcus sp. HIT [57] (GB
M34833), Zea maize HIT [31] (GB Z29643), Caenorhabditis elegans
HIT (GB Z71261), Bos taurus HIT [32] (GB U09405), and Homo
sapiens PKCI (HIT) [3] (GB U51004). It was previously determined
that PKCI contains an N-terminal acetyl group [3] in place of the
N-terminal methionine similar to that identified for endogenous bovine
HIT protein. Vertical arrows demarcate exons which includes the
region of exons 5–9 in the coding region of FHIT. Secondary structural
elements for FHIT are indicated above the FHIT polypeptide sequence
whereas secondary structural elements for PKCI are indicated below
the PKCI polypeptide sequence. Helices are denoted by boxes, b
strands by black arrows, and polypeptide chain by a bold black line.
Disordered regions in the respective structures are represented by
dashed lines. Residues highlighted by bold characters are either totally
conserved within the entire HIT family or are involved in ligand binding.
All numbering relates to the FHIT sequence (top line). Phe5 of FHIT is
highly conserved and located below the nucleotide base in the ligand-
binding pocket. Ala24 of FHIT is totally conserved in the HIT family.
Residue 27 of FHIT directly contacts the nucleotide ribose. Prolines at
FHIT positions 30 and 40 are highly conserved in the HIT family.
Histidines at FHIT positions 35, 94, 96 and 98 are totally conserved in
the HIT family and comprise a major portion of the active site; they are
involved in catalysis and phosphate binding as is residue 83. The
glutamine at FHIT position 90 is involved in stabilizing strands six and
seven (FHIT notation) in a splayed conformation.
the active site, possibly providing specificity for the
binding of the non-AMP portion of the respective ligands.
The highest degree of amino acid conservation between
PKCI and FHIT is observed in the ligand-binding pocket
and notably includes FHIT residues His35, His94, His96
and His98. Three water molecules, 1W–3W, located
between strands six and seven, and behind the phosphate,
are conserved in all FHIT and PKCI structures, including
other complexed and free forms of both protein molecules
(CDL, unpublished results). An additional water, 4W,
which is within hydrogen-bonding distance to a phosphate
oxygen and the other conserved waters, is found only in
the product (AMP) complex of FHIT (Fig. 5). Residues
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Figure 4
Comparison of the structures of GalT, PKCI and FHIT. (a) Ribbon
diagrams of GalT, PKCI and FHIT. Note the similar overall fold
conserved between these proteins. Histidine residues implicated in
catalysis in the mechanism are shown in red (ball-and-stick) and
include: GalT, His166; PKCI, His112; and FHIT, His96. The GalT
monomer has only one active-site histidine located on the right side of
GalT in the diagram, whereas the HIT dimers have two equivalent
active sites. Comparison of PKCI to GalT reveals an additional
structural analog to the N-terminal helix (color-coded dark blue) of
PKCI, which is found in the dimerization half of the GalT monomer
(located on the left side of the GalT monomer in the diagram). This
helix is missing in the active-site half (right side) of the GalT monomer.
Similar features can be observed in comparison of the FHIT and GalT
structures. The C-terminal helix of FHIT (color-coded magenta) is
absent from PKCI, but is present in the dimerization half (left side) of
the GalT monomer. Again, this helix is absent from the active-site half
of the GalT monomer. In addition, the disordered loop in FHIT between
strands 7 and helix B corresponds well in position and number of
residues with a loop in GalT which is involved in extensive interactions
in the GalT dimer and active site of the dimer partner (labeled ‘loop’ in
the FHIT structure and color-coded magenta in the GalT structure). (b)
Close-up of the active-site regions for GalT, PKCI and FHIT in their
apo or free forms. Only a subset of residues in the active site are
depicted on a Ca backbone spline for clarity. Residues depicted most
importantly include the active-site histidines of each protein (GalT,
His166; FHIT, His96; PKCI, His112). Interestingly, several
hydrophobic residues that make contact to the nucleoside base are
somewhat conserved (FHIT, Phe5 Leu37 and Leu25, and the
homologous residues in GalT and PKCI). The residue responsible for
binding the nucleoside ribose is somewhat conserved among FHIT,
PKCI and GalT (Asn27, Asp43 and Asn77, respectively). Although
these similarities are striking, two major differences exist between GalT
and the two HIT family members: firstly, GalT is missing two of the
highly conserved histidine residues in the active site; and secondly,
FHIT His98 or PKCI His114 is replaced by GalT Gln68 and FHIT
His35 or PKCI His51 is replaced by GalT Ser106. These substitutions
are likely to play some role in dictating and differentiating substrate
specificity between the GalT-related enzymes and the HIT protein
family.
surrounding the nucleotide base and ribose are generally
less well-conserved between PKCI and FHIT, suggesting
that alternative ligands/bases could interact with binding
sites on either FHIT or PKCI. Especially notable among
the predicted common features in ligand binding between
FHIT and PKCI are the many direct contacts and interac-
tions between the a phosphate group in respective ligands
and the active-site residues in respective proteins, thus,
implying that although PKCI and FHIT probably interact
with different substrates, catalysis at the a phosphate
group proceeds through a similar pathway. Two complexes
between a nucleotide monophosphate and the rabbit HIT
protein have been reported [4]. The FHIT–nucleotide
complex is in agreement with those complexes of the
rabbit HIT protein in regards to the general interactions
with the nucleotide base, ribose and sugar.
Structural and functional similarity to galactose-1-
phosphate uridylyltransferase
A structural analog to the HIT family of proteins has
recently been uncovered by analysis of the Protein Data
Bank [37,38]. In this analysis, it was found that although
no overall sequence similarity is observed, the human
PKCI dimer [3] was structurally similar to a protomer of
galactose-1-phosphate uridylyltransferase [39,40], also
known as GalT. A subsequent comparison between the
rabbit HIT protein and GalT was also recently described,
although the methods used to determine similarity were
not described [4]. GalT catalyzes the exchange of a UMP
moiety between the hexose-1-phosphates of glucose and
galactose, thus exchanging UDP-glucose and galactose-1-
phosphate with UDP-galactose and glucose-1-phosphate,
a nucleotidylyl phosphotransferase reaction. The GalT
phosphotransferase reaction is catalyzed by a histidyl
residue [39], in a manner which we believe to be similar
to that observed in the reactions of FHIT and PKCI
(CDL, unpublished results), members of the HIT family
of proteins. When a detailed structural comparison of
these proteins is made, similarities in the overall fold are
seen between the GalT protomer and the PKCI and
FHIT homodimers (Fig. 4). It should be noted that
although two active sites exist per HIT dimer, only one
active site exists per GalT protomer while the other half
of the GalT protomer is involved in dimerization interac-
tions in the GalT dimer. A structure-based sequence
alignment establishes weak sequence similarity between
GalT and the HIT proteins. The sequence identity of
aligned structural elements is 17.4% between 155 amino
acids of the GalT protomer with the two PKCI protomers
and 14.9% between 168 amino acid residues of the GalT
protomer and the two FHIT protomers. When the HIT
protomers are aligned with the active-site half of the GalT
protomer they have weaker sequence identity than with
the other half, which has 18.8% identity with PKCI and
19.8% identity with FHIT. No available sequence analy-
sis software identified any similarity between PKCI and
GalT or FHIT and GalT.
The structural alignment of all corresponding mainchain
atoms of the respective protomers in the HIT dimers and
the GalT protomer revealed that PKCI aligns with an
rmsd of 2.1Å to the active site half of the GalT protomer
and with 2.6Å to the dimerization half of the GalT pro-
tomer. FHIT aligns with an rmsd of 1.9Å and 2.0Å with
the respective halves of the GalT protomer. A structural
comparison of the respective halves of the GalT protomer
revealed that they align with one another to an rmsd of
1.8Å. It is interesting to note that although the active-site
half of the GalT protomer does not share common struc-
tural elements with either the N-terminal helix of PKCI or
the C-terminal helix and loop between strand 7 and the C-
terminal helix of FHIT, the dimerization half of the GalT
protomer does (Fig. 4a). Thus, aspects of the active site
were apparently conserved in one half of the GalT pro-
tomer, whereas several common structural elements were
conserved in the other. Similarity in the region of the
active site is especially notable with respect to the catalytic
histidine residues implicated in catalysis in GalT, FHIT
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Figure 5
Schematic stereo diagram of FHIT in
adenosine/sulfate product complexed form.
Hydrogen-bonding interactions thought to be
important in catalysis and ligand recognition
are depicted by dotted lines. To simplify the
depiction, only a subset of residues have been
shown superimposed on the Ca backbone
spline. Although most residues involved in
interactions between protein and adenine
base are not conserved between FHIT and
PKCI (not shown here), both proteins utilize a
deep hydrophobic cleft and water-mediated
contacts to the backbone of N-terminal
residues in binding the adenosine base.
and PKCI (Fig. 4b) (CDL, unpublished results). When the
three structures are aligned, the catalytic histidines (PCKI,
His112; FHIT, His96; and GalT, His166) superimpose
almost perfectly. All these histidines are coordinated
through their Nd atom to the respective carbonyl oxygen
of the other conserved histidines (PKCI, His110; FHIT,
His94; and GalT, His164) in the active site, leaving the Nε
of each catalytic histidine available to attack the a phos-
phorus atom of the respective substrates.
Although the similarities between these protein families
are striking, it should be noted that major differences exist
between the GalT and HIT protein families, not least that
the HIT protein homodimers correspond to a single GalT
protomer. The structural alignment would apparently
argue that FHIT and GalT are more structurally similar
than are GalT and PKCI, but the differences are so small,
and the sequence similarities weak enough that no defini-
tive evolutionary relationship can be constructed, even
between the two halves of the GalT protomer. Identical
residues observed among all known HIT family members
include four histidines in the vicinity of the active site, of
which only two are found in the GalT active site, and only
one is common to both halves of the GalT monomer and
to all other HIT protein sequences. This implies that
although the GalT and HIT family share an overall fold
capable of binding and catalyzing reactions with a
nucleotide polyphosphate, the specificity for respective
substrates and products may differ substantially. GalT
sequences from human and Escherichia coli have 56% iden-
tity, whereas the sequences among mammalian GalT
family members are approximately 90% identical. In both
cases, only weak sequence identity is found between HIT
family members and GalT family members. As was stated
before, the sequence identity among the PKCI HIT
family members apparently corresponds well with the
level of conservation within the GalT family, with 47%
identity between E. coli and human, and greater than 94%
identity between mammalian homologs of PKCI. If the
GalT and HIT proteins share some very distant evolution-
ary link, it appears that the two families would have
diverged long ago and conserved their independent func-
tions, which subsequently led to two independent well-
conserved protein families that share some chemical
characteristics in their active sites, but no longer share
common substrate specificity.
Mechanistic implications
Several aspects of the HIT family catalytic mechanism can
be inferred from the data provided by the structures of HIT
proteins in their apo (ligand-free) forms and the structure of
the FHIT–adenosine/sulfate complex. If the reaction inter-
mediate proceeds through a nucleotidylyl– histidyl covalent
intermediate, as it does in the GalT reaction with its
respective substrates, several catalytic requirements must
be met. These include the activation of a histidine to
initially attack the a phosphate and the subsequent activa-
tion of a second nucleophile to attack the phosphoramidate
bond, thus releasing the nucleotide monophosphate
product. This reaction pathway has been previously
observed using two histidines [40–44]. In the mechanism
for 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase,
one histidine acts as the nucleophile to attack the phos-
phate, whereas the other acts as a base to deprotonate a
water to produce the hydroxyl ion capable of attacking and
releasing the covalent phosphohistidyl intermediate. 
Structural analogy with this enzyme and GalT indicate
that His96 of FHIT and His112 of PKCI act as the nucle-
ophile in the inversion of the a phosphate in these reac-
tions. Evidence for this mechanism includes the fact that
respective histidine residues appear highly stabilized by a
conserved structural motif, whereby the carbonyl oxygen
atom of FHIT His94 or PKCI His110 is hydrogen bonded
in a close interaction with the Nd atom of FHIT His96 or
PKCI His112 (with distances between the two histidine
residues of 2.5Å for FHIT and 2.6Å for PKCI). This indi-
cates indirectly that the Nε atom of FHIT His96 or PKCI
His112 is deprotonated in the apo form of the enzyme at
neutral pH and properly oriented to attack the phosphate
group as it enters the binding pocket.
Kinetic studies on FHIT subjected to the site-directed
mutagenesis of its four conserved histidines are consistent
with our model for catalysis. Barnes et al. have found that
mutation of His35 or His94 to asparagine reduces catalytic
efficiency of FHIT by 36% and 69%, respectively [20].
Mutation of His98 to asparagine reduces activity to less
than 2.5%, and when His96 is mutated to asparagine all
detectable activity is ablated. We predict, on the basis of
the structural evidence in both PKCI and FHIT and the
mutagenesis data, that His96 is required for activity
because it is directly involved in the nucleophilic attack
and inversion of the a phosphate and in the covalent inter-
mediate with the nucleotide monophosphate. His98 may
likely be involved in the deprotonation of the water
responsible for attacking and releasing the covalent inter-
mediate. An analogous mutagenic study in 6-phospho-
fructo-2-kinase/fructose 2,6-bisphosphatase revealed
similar behavior when the two active-site histidines were
mutated to other residues —mutations of His258, the
residue shown to be a phosphohistidyl residue during
catalysis, ablated all enzymatic activity, and those of
His392 diminished activity to less than 5% [42]. In the
reaction catalyzed by this enzyme, His392 has been impli-
cated as a proton donor and acceptor. Because of the simi-
larity of residues in the vicinity of the active site among
PKCI, FHIT and GalT, we propose the catalytic mecha-
nism for PKCI and FHIT be extended to all HIT family
members, especially with respect to the initial attack of
the a phosphate in the respective substrates. Although the
identity of the in vivo substrate is yet to be shown for
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either enzyme or any other HIT family member for that
matter, it appears that these molecules catalyze reactions
that will proceed through a covalent nucleotidyl- phospho-
protein intermediate. Members of the HIT family of
enzymes are capable of catalyzing the hydrolysis of a phos-
phoanhydride bond under certain conditions, however, a
covalent enzyme intermediate suggests these enzymes
may be capable of catalyzing a transferase reaction of the
covalent intermediate instead of just a hydrolysis reaction
(a short-sighted and limited aspect of the in vitro hydrolase
assay). Clearly, this is something that should not be over-
looked in the search for in vivo HIT protein function.
Biological implications
Here we report the successful MAD structure determi-
nation of the fragile histidine triad (FHIT) protein, a
member of a large and highly conserved family of pro-
teins known as the histidine triad (HIT) family of pro-
teins. Although their in vivo function is still unknown,
HIT proteins have been implicated in the binding and
hydrolysis of nucleotide polyphosphates. It is likely that
such a highly conserved family of enzymes, shown by
the high sequence similarity among organisms ranging
from mycoplasma, archae, bacteria, plants and humans,
are involved in some critical and ubiquitous biochemical
pathway that remains undiscovered.
FHIT, a gene that resides within a fragile site of human
chromosome 3, has been postulated to be a human tumor
suppressor gene. Unlike the p53 gene, no point mutations
have been discovered in the coding regions of the FHIT
gene which would alter the ability of FHIT to catalyze
the hydrolysis of nucleotide polyphosphates. Instead, dis-
ruptions and translocations seem to be the major factors
that alter the FHIT translation product. These alter-
ations usually affect only one copy of the FHIT gene in
the genome, leaving one full length copy available in the
cell. On the basis of the structure of the FHIT protein, it
is unlikely that truncated forms of the protein resulting
from altered FHIT transcripts would be capable of
folding and interacting with the full length gene product,
thus, eliminating the possibility of a dominant negative
phenotype when one altered FHIT transcript exists in the
cell with one full length copy of the gene.
This study provides the first structure of FHIT, a diverse
member of the HIT family of proteins, and suggests that
distant members within the HIT superfamily share a
similar overall fold and catalytic mechanism, some
features of which can be extended to and inferred from
the GalT family of proteins. As the catalytic activity
observed in vitro demonstrates the ability of these
enzymes to hydrolyze their substrates, it is likely that
these enzymes could behave as nucleotidyl phosphotrans-
ferases through a pathway mediated via a covalent
enzyme intermediate—several features of which can be
inferred from the FHIT–nucleotide-analog complex.
These studies support a mechanism in which the nucle-
ophilic attack by respective histidines in various HIT
family members at the a-phosphorus atom would result in
a transient covalently attached nucleotidyl–protein inter-
mediate before hydrolysis of the phosphoramidate bond.
Materials and methods
Cloning, protein expression and purification
The cDNA for FHIT was obtained [5] and subcloned into the pGEX-2T
vector for over-expression in E. coli [45]. The protein was purified ini-
tially by passage over a glutathione-sepharose and MonoQ (Pharma-
cia) columns. The fusion protein was cleaved with thrombin and
passed over these two columns again in the same order. A final purifi-
cation step was applied using a Superdex 200 size exclusion column
(Pharmacia). The protein was concentrated to ∼3mg/ml and stored at
–80°C in 5.0 mM Tris-HCL pH7.4, 1.0 mM DTT.
Crystallization
FHIT was crystallized using a partial factorial screen [46]. Final condi-
tions were obtained whereupon crystals of both native and selenome-
thionyl FHIT could be grown reproducibly. These conditions are
~10 mg/ml protein, 1.25–1.35 M AmSO4, 100 mM sodium cacodylate
pH 6.5. Crystals grown under either condition were in space group
P6122 with unit cell dimensions of a = 50.6Å, b = 50.6Å, c = 268.0Å,
a = 90°, b = 90° and g = 120°.
Data collection and processing
All data was collected on cryo-preserved crystals at 110K. Crystals
were cryo-protected in a sucrose–AmSO4 solution prior to cooling.
The two four wavelength MAD experiments were collected at the APS
SBC undulator beamline 19-ID on an IP system and the CCD detector
[23]. The single wavelength experiment on Native2 was collected at
the Howard Hughes beamline X4A at Brookhaven National Laboratory
using an IP system. All IP and RaxisII data was process using DENZO
and SCALEPACK [47]. CCD data was initially processed at the APS
[48]. Subsequent data reduction was done using the CCP4 suite of
programs [49] (Tables 2 and 3).
MAD data collection
Crystals were oriented with the c axis on the camera spindle in order to
collect Bijvoet pairs on the same or adjacent images. A four wave-
length IP data set was collected on a 0.1 mM adenosine/vanadate-
soaked selenomethionyl crystal. Eight 30° segments (with the long axis
parallel to the spindle) and four 20° segments (orthogonal to the previ-
ous orientation) of data were taken on the IP system. Only seven 30°
segments of data were taken with the CCD detector. Rotations of 2.0°
per 30 seconds with 0.5° overlap were taken using the IP system. Only
fully recorded reflections were used in the IP-data processing. Rota-
tions of 0.2° per 10 seconds were taken using the CCD detector by
continuously summing partials. The wavelength and gap, if necessary,
would be changed between each segment during data collection.
Although this was not optimal for MAD phasing due to sample decay
and ice build-up, it was a compromise between manual gap width
changes and the speed of data collection. 
Phasing
A selenium site was identified in a Bijvoet difference Patterson. This
site was used to locate a second selenium position in a Bijvoet differ-
ence Fourier with phases generated to 2.8 Å from all the IP data
using MADSYS [21]. The third potential selenium site corresponding
to the N-terminal methionine was not revealed and was later found to
be disordered. MAD phases were determined to 2.8 Å using the two
selenium positions. MAD phases were determined for the CCD data
using only the first four 30° segments of data. Combining further seg-
ments of data completely degraded the quality of the phases due to
unknown problems with the last two segments of data. Because
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these data were very incomplete, phased reflections to 5.0 Å were
used from the IP data set to augment the phase set obtained from the
CCD data to 2.0 Å which underwent several rounds of density modifi-
cation [25] at 2.0 Å. Correlation coefficients have been calculated
using O between the final Fc maps, MAD phased maps, and solvent
flattened maps. The IP-MAD map has a correlation of 0.579 between
the 2.8 Å MAD map and refined Fc map for the adenosine/sulfate
structure. A correlation coefficient of 0.372 was calculated between
the final 2.0Å Fc map of the native structure and the 2.0 Å MAD data
augmented with up to 5.0 Å data from the IP data set. This map was
not readily interpretable at this stage. When solvent flattening was
applied to these data, the calculated correlation coefficient rose to
0.673 between the solvent flattened 2.0 Å map and the final Fc map.
Refinement
Two independent polypeptide chains were traced into the 2.8 Å adeno-
sine-soak MAD map and apo-CCD map, respectively, using O [26]. All
subsequent structures were solved using partial models in molecular
replacement with AMORE [50]. All models were refined with X-PLOR
using the cross-validation test [51,52]. Each model was put through
one simulated annealing round with all subsequent phase extension
and refinement accomplished with positional least-squares refinement.
Each FHIT model roughly includes residues 2–108 and 125–147.
Anisotropic B-factor refinement and scaled Fobs were generated (as
implemented by X-PLOR) on FHIT data sets before the addition of
waters to the model. Subsequent refinement and reported Rvalues uti-
lized the scaled data for FHIT (Table 4).
Accession numbers
Coordinates have been deposited in the PDB with accession codes
1fit, 2fit and 3fit.
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